Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24327334 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
Condition: Breast Cancer
Interventions: Drug: Everolimus;   Drug: Fulvestrant

Indicates status has not been verified in more than two years